A supply chain to match the changing face of science
Drug Discovery World
NOVEMBER 3, 2022
They also do not have the potential of causing a severe immune response if they are administered to the wrong patient. As such, there was little in both the traditional pharma and medical device supply chain processes that was a good fit for advanced therapy developers. . 15 years later . References .
52 
Let's personalize your content